Jarvik Heart, Inc. specializes in the development of advanced ventricular assist devices (VADs) designed to support patients with severe heart failure. Their flagship product, the Jarvik 2000, is a miniaturized, implantable heart pump that provides continuous blood flow, significantly improving the quality of life for patients awaiting heart transplants or those who are not candidates for surgery. The device is engineered to be less invasive and more efficient than traditional heart pumps, utilizing a unique design that minimizes blood trauma and enhances patient safety.

In addition to the Jarvik 2000, the company is actively engaged in research and development of next-generation heart assist technologies. This includes innovations aimed at improving the biocompatibility of devices, reducing the risk of complications, and enhancing the overall performance of VADs. Jarvik Heart, Inc. is committed to advancing cardiac care through its cutting-edge technologies, which are backed by rigorous scientific research and clinical trials, ensuring that their products meet the highest standards of safety and efficacy for patients with heart failure.

United States

Jarvik Heart Inc. is a developer and manufacturer of life sustaining miniaturized cardiac (heart) assist devices, founded by Dr. Robert Jarvik, the inventor of the first permanent total artificial heart.

333 W 52nd St Ste 700, New York, New York 10019-6238, US

Jarvik Heart, Inc.

Company Details